… , MD, of Memorial Sloan Kettering Cancer Center, stated during the presentation … ], and oxaliplatin) for systemic chemotherapy and 5-fluorouracil (5-FU) plus oxaliplatin CRT at 50 …

… 1.The chemotherapy regimen may include various agents such as 5-Fluorouracil (5-FU), followed … pathogenesis of sporadic colorectal cancers. Chin J Cancer. 2016;35:4. … outcome in advanced colorectal cancer patients receiving chemotherapy with or without …

… recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum … cell and therapeutic implications in cancer. Cancer Lett. 2023;567:216267. … Redox Status and Chemoresistance in Human Angiosarcomas. Clin Cancer Res. 2018; …

… either pembrolizumab, lenvatinib, and chemotherapy or chemotherapy alone. During the induction … 5-fluorouracil (5-FU) plus 2400 mg/m2 of continuous intravenous 5-FU … standards. “Gastric and gastroesophageal cancers continue to present challenges due …

… therapy with mitomycin C and 5-fluorouracil: a review of their use …

… , FLOT, cisplatin/Xeloda, or 5-fluorouracil. Additionally, patients received perioperative Herceptin … folinic acid and 82% for 5-fluorouracil. Additional efficacy findings showed that …

… effect of ribociclib (LEE011) and 5-fluorouracil on human colorectal cancer. Anticancer …

… combination of folinic acid plus 5-fluorouracil plus oxalplatin (5; 6.5% …

… docetaxel, cisplatin, and 5-fluorouracil (DCF) in patients … [docetaxel, cisplatin, and 5-fluorouracil] therapy, patients might … [docetaxel, cisplatin, and 5-fluorouracil] therapy.” Despite these efforts … docetaxel, cisplatin, and 5-fluorouracil therapy in the …

… . All patients had received prior 5-fluorouracil, and most had also received …